Eureka! Turning Scientific Discoveries into Gold Thursday, Nov 10, 2016 6:00 PM - 9:00 PM EST
7th Floor Conference Center, University Hall Map Location
Sign in or register to RSVP to this event Today is perhaps the most important moment in time for bringing science and technology together through entrepreneurship – we know more scientifically than we ever have, and new knowledge is being added daily. How can entrepreneurs connect with experts in science and technology to form meaningful, and potentially profitable, partnerships? Those of us making novel discoveries at universities would like to see our discoveries used for the benefit of society. This panel discussion will explore the best way to do that with insights from professionals who have “been there and done that.” While scientists pursue science for the sheer importance of discovery, it is through commerce that society places value on ideas that solve problems. We look forward to seeing you at this panel discussion as we consider how science can be not just intellectually stimulating and fun, but financially profitable. Agenda: 6:00 p.m. Networking and Pizza 6:45 p.m. Opening Remarks - Sam Kongsamut, Founder, Rudder Serendip 6:55 p.m. Introductions and Setting the Platform 7:00 p.m. The Panel: • Keith Bostian, CEO, Institute for Life Science Entrepreneurship & Dean, NJ Center for Science, Tech & Mathematics and Tech Transfer at Kean University • Mario Casabona, Founder & CEO, TechLaunch LLC and CEO, Casabona Ventures • Francis Cuss, Executive VP and CSO, R&D, Bristol-Myers Squibb • Phillip Loew, Business Manager, NYC Regional Innovation Node(NSF iCorps funded) • Diana Thomas, Director, Center for Quantitative Obesity Research, Montclair State University Moderator: Robert Prezant, Dean, College of Science and Mathematics, Montclair State University 7: 45 p.m. Q&A followed by Networking until 9:00 p.m. Event is free and open to the public. Event presented by Montclair State's College of Science and Mathematics and the Feliciano Center for Entrepreneurship. Join the conversation on Twitter and Instagram: #MSUmeetupand @FelicianoCenter and @MSUCSAM Directions and parking info: Park in the Red Hawk Deck on campus, exit the deck on Level 5 and proceed straight up the walkway (soccer field will be on your left). At the new Feliciano School of Business building, go up the outdoor staircase. University Hall will be straight ahead once you reach the top of the steps. Campus map with directions. (Please note the map in that link is old--the tennis courts shown on the map is where the Feliciano School of Business building now stands.) Speaker bios: Keith Bostian has held executive operating roles in VC-backed biotechnology companies, and has played advisory roles for numerous other organizations, securing over $275 million in financing. He was CEO at Vanta/Amalyte, a founder of Mpex Pharmaceuticals, a development-stage pharmaceutical company in the infectious disease arena, founder and CEO of Iconix Pharmaceuticals, Inc., a pioneer and leader in chemogenomics, and founder and COO of Microcide Pharmaceuticals, Inc., a publicly traded company and one of the first biotech companies formed to focus on antibiotic resistant bacteria. Keith was previously Head of Microbiology and Molecular Genetics at Merck Research Laboratories, responsible for the discovery and development of new anti-microbial agents, including new leads from natural products for all of Merck's worldwide drug discovery programs. He is an inventor on numerous patents in drug discovery and genomics, and has led efforts resulting in a number of clinical candidates and commercial products. Mario Casabona is an Entrepreneur and Angel Investor. He is Founder of TechLaunch LLC, a Business Accelerator, of Casabona Ventures, a micro-VC fund, providing early-stage financing to technology companies, and he was Chairman of Jumpstart New Jersey Angel Network (2009 to 2012). In 1982 he founded and was CEO of Electro-Radiation Inc. (ERI); ERI was a developer of Radar, Navigation and Communications technology and was acquired by Honeywell International in 2004. In 1998, he was awarded the SBA National Tibbett's Award. In 2010 he was awarded the Financier of the Year award and in 2013, the Legend of Technology award, both by the New Jersey Technology Council. In 2014, he was recognized by the NJ Star Ledger as a top influential person in NJ Technology. Mario serves on several forprofit and non-profit boards. He is an Electrical Engineer and holds 12 national and international patents in satellite-based navigation and communications. Francis Cuss, MB BChir, FRCP, is the Executive Vice President and Chief Scientific Officer, R&D at Bristol-Myers Squibb. Dr. Cuss has served as Chief Scientific Officer since July 2013, and has been a member of the company’s Senior Management Team since 2010. He is a physician with a background in general and academic medicine and broad experience in pharmaceutical R&D. Prior to joining BMS in 2003, he spent 14 years at Schering-Plough and three at Glaxo, where his career included leadership roles in discovery, clinical research and medical affairs in the U.S. and Europe. Sam Kongsamut obtained his PhD at the University of Chicago and had postdoctoral training at Cornell and Yale Universities. He joined the pharmaceutical industry in 1991, working for a succession of five different companies (Hoechst-Roussel Pharmaceuticals Inc, Hoechst Marion Roussel, Aventis, sanofi aventis. now sanofi), leading a variety of drug discovery and development projects covering a range of neuroscience areas, and helping to translate animal pharmacology to human pharmacology. More recently, Sam was Director of External Innovation at sanofi-aventis, using his experience for licensing. Since leaving Sanofi in 2012, Sam founded Rudder Serendip LLC, serving clients at universities, foundations and biotechnology companies. Philip Loew serves as the Business Manager of the NYC Regional Innovation Node (NYCRIN), a $3.74M collaborative program, funded by the National Science Foundation Innovation Corps (I-Corps), and led by the City University of New York (CUNY) in partnership with New York University and Columbia University. In this capacity, he manages the day-to-day operations of the Node yet also builds effective relationships with existing and new companies. Additionally, Mr. Loew serves as an Associate Director of strategic initiatives and partnerships. His most recent project includes a community college innovation competition. Prior to joining NYCRIN, Mr. Loew worked in several roles within the Investment Bank of J.P. Morgan Chase. Mr. Loew graduated Magna Cum Laude from Macaulay Honors College on a full scholarship. He holds a Bachelor of Business Administration in Finance with a double minor in Sociology and Interdisciplinary Arts. Robert S. Prezant is Dean of the College of Science and Mathematics at Montclair State and Professor of Biology. His external funding, approximating $6.5M, comes from federal, state, and industry sources. He was President of the American Malacological Society and serves or has served on the NJ Sea Grant Board of Directors, Passaic River Basin Flood Advisory Commission, NJ R&D Council, and Board of Trustees of the Hackensack University Medical Center Mountainside. He is a named University Professor at Indiana University of Pennsylvania. Dr. Prezant served as Editor-in-Chief of the American Malacological. He holds a Ph.D. in Marine Biology from the College of Marine Studies, University of Delaware. Diana M. Thomas received her doctorate in mathematics from the Georgia Institute of Technology. She was a Davies Postdoctoral Fellow at the USMA followed by an assistant professorship at New Jersey City University before she began her tenure at Montclair State in Mathematics. Dr. Thomas has worked extensively at the interface of mathematics and obesity. Her models have been developed and programmed into the weight loss intervention platform, SmartLoss™ Virtual Weight Management Suite. SmartLoss™ has been used by Jenny Craig and licensed to external industries for remote weight management solutions. She has also worked closely with the pharmaceutical industry on models for different levels of drug discovery and delivery. She is currently funded by the NIH to work on obesity related modeling. Dr. Thomas directs the MSU Center for Quantitative Obesity Research and the Montclair State University Weight Management Clinic.
C R EATED Oct 25, 2016 by Lori A Rowbotham U PD ATED Oct 26, 2016 by Lori A Rowbotham VISIBL E TO Everyone C ATEGOR Y General